Ignite Creation Date:
2024-05-05 @ 9:36 PM
Last Modification Date:
2024-10-26 @ 10:07 AM
Study NCT ID:
NCT00925717
Status:
COMPLETED
Last Update Posted:
2010-01-26
First Post:
2009-06-19
Brief Title:
of PATient Education Related to CV Risk factOrs in Type 2 Diabetes MellitusPatrol
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
of PATient Education Related to CV Risk factOrs in Type 2 Diabetes MellitusPatrol
Status:
COMPLETED
Status Verified Date:
2010-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DART
Brief Summary:
An observational non-interventional multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP hs-CRP testing and characteristics of each CVD risk group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None